Welcome to CSNpharm! For Research Use Only!
Sodium Channel
| Cat. No. | Product Name | CAS No. | Information |
|---|---|---|---|
| CSN25305 | Tenapanor | 1234423-95-0 | Tenapanor is an inhibitor of the sodium-proton (Na(+)/H(+)) exchanger NHE3, which plays a prominent role in sodium handling in the gastrointestinal tract and kidney, with IC50 values of 5 and 10 nM against human and rat NHE3, respectively. |
| CSN12787 | Ranolazine dihydrochloride | 95635-56-6 | Ranolazine 2HCl is a calcium uptake inhibitor via the sodium/calcium channal, used to treat chronic angina. |
| CSN18533 | PH-064 | 892546-37-1 | PH-064 is a sodium channel inhibitor. It is also a selective Gαq inhibitor. It traps Gαq in the empty pocket conformation by permitting GDP exit but interdicting GTP entry. |
| CSN26169 | PF-06305591 | 1449473-97-5 | PF-06305591 is a potent and highly selective voltage gated sodium channel NaV1.8 blocker, with IC50 of 15 nM. It shows excellent preclinical in vitro ADME and safety profile. |
| CSN26313 | PF-01247324 | 875051-72-2 | PF-01247324 is a selective Nav1.8 channel blocker with an IC50 of 196 nM. |
| CSN26179 | N-Me-aminopyrimidinone 9 | 1356834-62-2 | N-Me-aminopyrimidinone 9 is an improved Nav1.7 antagonist with minimal off-target hERG liability, and improved rat PK properties. |
| CSN21733 | Nicotinoyl cyclandelate | 39537-99-0 | Micinicate, a local anesthetic, can reversibly block transient Na+ inward current as well as the steady-state K+ outward current. |
| CSN25458 | Licarbazepine | 29331-92-8 | Licarbazepine, also known as BIA-2-005; GP-47779; LIC-477; LIC-477D; TRI-477, is a voltage-gated sodium channel blocker with anticonvulsant and mood-stabilizing effects that is related to oxcarbazepine. It is an active metabolite of oxcarbazepine. In addition, an isomer of licarbazepine, eslicarbazepine ((S)-(+)-licarbazepine), is an active metabolite of eslicarbazepine acetate. Oxcarbazepine and eslicarbazepine acetate are inactive on their own, and behave instead as prodrugs to licarbazepine and eslicarbazepine, respectively, to produce their therapeutic effects. |
| CSN12998 | Lamotrigine | 84057-84-1 | Lamotrigine is a member of the sodium channel blocking class of antiepileptic drugs which can block L-, N-, and P-type calcium channels and has weak 5-HT3 receptor inhibition. |
| CSN21637 | Sodium ionophore III | 81686-22-8 | ETH2120 is a Na+ ionophore suitable for the assay of sodium activity in blood. |
| CSN25462 | EIPA | 1154-25-2 | EIPA (L593754) is a TRPP3 channel inhibitor with an IC50 of 10.5 μM. EIPA also inhibits Na+/H+-exchanger (NHE) and macropinocytosis. |
| CSN25620 | DSP-2230 | 1233231-30-5 | DSP-2230 is a selective Nav1.7/Nav1.8 blocker. |
| CSN51363 | AZ194 | 2241651-99-8 | CRMP2-Ubc9-NaV1.7 inhibitor 194 is a CRMP2-Ubc9-NaV1.7 inhibitor. |
| CSN41903 | Benzamil | 2898-76-2 | |
| CSN38648 | GNE-0439 | 1241902-40-8 | |
| CSN38350 | Nav1.1 activator 1 | 2332897-85-3 | |
| CSN35591 | AM-2099 | 1443373-17-8 | |
| CSN35584 | PF-04856264 | 1235397-05-3 | |
| CSN43403 | Nav1.7-IN-3 | 1788872-06-9 | |
| CSN43405 | GNE-616 | 2349371-81-7 | |
| CSN43828 | PF-05198007 | 1235406-19-5 | |
| CSN43402 | PF-05241328 | 1387633-03-5 | |
| CSN51358 | GX-674 | 1432913-36-4 | |
| CSN63043 | PF-05186462 | 1235406-03-7 | |
| CSN63066 | TC-N 1752 | 1211866-85-1 | |
| CSN63457 | (R)-Funapide | 1259933-15-7 | |
| CSN67373 | GX-201 | 1788071-27-1 | |
| CSN67909 | GDC-0310 | 1788063-52-4 | |
| CSN76031 | Nav1.8-IN-1 | 1026822-49-0 | |
| CSN51561 | 3-Amino-5-(4-methoxyphenyl)thiophene-2-carboxamide | 354812-16-1 |
+1-708-781-1677
+1-708-286-6026
sales@csnpharm.com
